Company: BNBX
Filing Date: 2025-09-29
Form Type: 8-K
Source: 0001104659-25-094465
Chunk: 1

Company: BNB PLUS CORP.
Filing Date: 2025-09-29
Form: 8-K
Item: Item 1.01
Chunk 1
---
arrants.

The Company intends to close the Offering on
or around on October 1, 2025 (the “ Closing Date”). The gross proceeds of the Offering are expected to be approximately $26.8
million. Unless otherwise indicated, capitalized terms used but not defined in this Item 1.01 shall have the meanings set forth in the
Securities Purchase Agreement, as applicable.

Prior to the Closing Date, the Company was a biotechnology
company focused on providing nucleic-acid production solutions for the biopharmaceutical and diagnostics industries. The Company’s
technologies enabled cell-free manufacturing of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which are essential components
for a new generation of advanced biotherapeutics, such as gene therapies, adoptive cell therapies, messenger RNA therapeutics and DNA
vaccines, as well as diagnostic applications.

The Company intends to use the net proceeds
from the Offering for working capital purposes and will primarily use such proceeds in its BNB-focused treasury strategy wherein it
will manage digital assets, primarily in the native cryptocurrency of the Binance Coin blockchain commonly referred to as
“ BNB”, including staking, restaking, and liquid staking of BNB, and participation in other Binance ecosystem yield
opportunities to contribute the BNB to the Company’s treasury operations (together, the “ BNB Strategy”).

Each of the Prefunded Warrants and the
Cryptocurrency Prefunded Warrants is exercisable for one share of Common Stock at the exercise price of $0.0001 per share of Common
Stock underlying the Prefunded Warrant or Cryptocurrency Prefunded Warrant (a “ Prefunded Warrant Share”). The Prefunded
Warrants are immediately exercisable and may be exercised at any time until all of the Prefunded Warrants issued in the Offering are
exercised in full. The Cryptocurrency Prefunded Warrants are exercisable on or after the later of (i) the date the Stockholder
Approval is obtained and (ii) the date that the Subscription Amount is delivered in transferrable form reasonably acceptable to the
Company with good and marketable title and is free and clear of any security interests, pledges, liens, restrictions, claims or
encumbrances of any kind, and thereafter may be exercised at any time until five (5) years after the date of their initial issuance.
Each holder’s ability to exercise its Prefunded Warrants or Cryptocurrency Pref